{"lastClose": 11.989999771118164, "len": 1206, "date": "2023-03-10", "alpha_1": 0.7245193890458068, "beta_1": 0.9016419251286448, "drawup_1": 1.2434209803960319, "sharpe_1": 0.6054132110711521, "natr_1": 5.643445336021898, "sup_1": -0.05212672027923108, "res_1": 0.19099252072220063, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 37.48411502112201, "adx_1": 8.474348379152566, "drawdown_1": -0.33391761557680333, "stratHoldSharpe_1": 0.5903064493918271, "stratHoldAlpha_1": 251.32003100902352, "stratHoldDrawdown_1": -0.30458340556694896, "alpha_3mo": -0.629053623567489, "beta_3mo": 0.6675931781174174, "drawup_3mo": 0.09349033384347871, "natr_3mo": 5.643445336021898, "sup_3mo": -0.027522929942081185, "res_3mo": 0.041701418644261655, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 25.223214048132025, "adx_3mo": 20.408200031070354, "drawdown_3mo": -0.24448646140013697, "stratHoldSharpe_3mo": -2.591637404988214, "stratHoldAlpha_3mo": 250.01707824468622, "stratHoldDrawdown_3mo": -0.2200655481010868, "Name": "Kiniksa Pharmaceuticals Ltd. Class A", "Market Cap": 829166262, "IPO Year": 2018.0, "Country": "United States", "Industry": "Biotechnology: Pharmaceutical Preparations", "Sector": "Health Care", "alpha%_1": 0.9944622965695492, "beta%_1": 0.44546786966527485, "drawup%_1": 0.9734394262079247, "sharpe%_1": 0.488166655560986, "natr%_1": 0.7392183400691802, "drawdown%_1": 0.5862317490001328, "stratHoldSharpe%_1": 0.7668093310513818, "stratHoldAlpha%_1": 0.8807597451205846, "stratHoldDrawdown%_1": 0.5863258933627972, "alpha%_3mo": 0.1033021798398232, "beta%_3mo": 0.29047460041682066, "drawup%_3mo": 0.18320502035279168, "natr%_3mo": 0.7355249431423282, "drawdown%_3mo": 0.179440244968753, "stratHoldSharpe%_3mo": 0.06955536006644328, "stratHoldAlpha%_3mo": 0.03557578243745319, "stratHoldDrawdown%_3mo": 0.19008170444225225}